BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16842735)

  • 1. Use of pseudosubstrate affinity to measure active protein kinase A.
    Paulucci-Holthauzen AA; O'Connor KL
    Anal Biochem; 2006 Aug; 355(2):175-82. PubMed ID: 16842735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Toxoplasma gondii cAMP dependent protein kinase and its role in the tachyzoite growth.
    Kurokawa H; Kato K; Iwanaga T; Sugi T; Sudo A; Kobayashi K; Gong H; Takemae H; Recuenco FC; Horimoto T; Akashi H
    PLoS One; 2011; 6(7):e22492. PubMed ID: 21799871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone secretion by luteinizing human granulosa cells: a possible cAMP-dependent but PKA-independent mechanism involved in its regulation.
    Chin EC; Abayasekara DR
    J Endocrinol; 2004 Oct; 183(1):51-60. PubMed ID: 15525573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulphonamide) induces autophagy independently of protein kinase A inhibition.
    Inoue H; Hase K; Segawa A; Takita T
    Eur J Pharmacol; 2013 Aug; 714(1-3):170-7. PubMed ID: 23810683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Stapled Peptide Mimic of the Pseudosubstrate Inhibitor PKI Inhibits Protein Kinase A.
    Manschwetus JT; Bendzunas GN; Limaye AJ; Knape MJ; Herberg FW; Kennedy EJ
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31009996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ca
    Fusi F; Trezza A; Spiga O; Sgaragli G; Bova S
    Biochem Pharmacol; 2017 Sep; 140():53-63. PubMed ID: 28583845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of Plasmodium falciparum cyclic AMP-dependent protein kinase and its mammalian homologue to the inhibitors.
    Sudo A; Kato K; Kobayashi K; Tohya Y; Akashi H
    Mol Biochem Parasitol; 2008 Aug; 160(2):138-42. PubMed ID: 18501980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of rat liver phosphoproteins after treatment with protein kinase inhibitor H89 (N-(2-[p-bromocinnamylamino-]ethyl)-5-isoquinolinesulfonamide).
    Davis MA; Hinerfeld D; Joseph S; Hui YH; Huang NH; Leszyk J; Rutherford-Bethard J; Tam SW
    J Pharmacol Exp Ther; 2006 Aug; 318(2):589-95. PubMed ID: 16687476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A PKA survival pathway inhibited by DPT-PKI, a new specific cell permeable PKA inhibitor, is induced by T. annulata in parasitized B-lymphocytes.
    Guergnon J; Dessauge F; Traincard F; Cayla X; Rebollo A; Bost PE; Langsley G; Garcia A
    Apoptosis; 2006 Aug; 11(8):1263-73. PubMed ID: 16761111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H89 (N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide) induces reduction of myosin regulatory light chain phosphorylation and inhibits cell proliferation.
    Umeda D; Yamada K; Tachibana H
    Eur J Pharmacol; 2008 Aug; 590(1-3):61-6. PubMed ID: 18579130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cAMP signalling pathway activates CREB through PKA, p38 and MSK1 in NIH 3T3 cells.
    Delghandi MP; Johannessen M; Moens U
    Cell Signal; 2005 Nov; 17(11):1343-51. PubMed ID: 16125054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The many faces of H89: a review.
    Lochner A; Moolman JA
    Cardiovasc Drug Rev; 2006; 24(3-4):261-74. PubMed ID: 17214602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sensitive electrochemical biosensor for detection of protein kinase A activity and inhibitors based on Phos-tag and enzymatic signal amplification.
    Yin H; Wang M; Li B; Yang Z; Zhou Y; Ai S
    Biosens Bioelectron; 2015 Jan; 63():26-32. PubMed ID: 25048450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation Changes in Response to Kinase Inhibitor H89 in PKA-Null Cells.
    Limbutara K; Kelleher A; Yang CR; Raghuram V; Knepper MA
    Sci Rep; 2019 Feb; 9(1):2814. PubMed ID: 30808967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kinase-Glo luminescent kinase assay for in vitro determination of PKA activity].
    Zhang Y; Wu YL; Liu Q; Chen C; Qin YY; Wu GY; Gao H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jul; 28(7):684-7. PubMed ID: 22768854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cAMP-Induced Histones H3 Dephosphorylation Is Independent of PKA and MAP Kinase Activations and Correlates With mTOR Inactivation.
    Rodriguez P; Rojas J
    J Cell Biochem; 2016 Mar; 117(3):741-50. PubMed ID: 26335579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nobiletin, a citrus flavonoid with neurotrophic action, augments protein kinase A-mediated phosphorylation of the AMPA receptor subunit, GluR1, and the postsynaptic receptor response to glutamate in murine hippocampus.
    Matsuzaki K; Miyazaki K; Sakai S; Yawo H; Nakata N; Moriguchi S; Fukunaga K; Yokosuka A; Sashida Y; Mimaki Y; Yamakuni T; Ohizumi Y
    Eur J Pharmacol; 2008 Jan; 578(2-3):194-200. PubMed ID: 17976577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanical loading stimulates chondrogenesis via the PKA/CREB-Sox9 and PP2A pathways in chicken micromass cultures.
    Juhász T; Matta C; Somogyi C; Katona É; Takács R; Soha RF; Szabó IA; Cserháti C; Sződy R; Karácsonyi Z; Bakó E; Gergely P; Zákány R
    Cell Signal; 2014 Mar; 26(3):468-82. PubMed ID: 24333667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic adenosine 3':5'-monophosphate-dependent protein kinase on the external surface of LS-174T human colon carcinoma cells.
    Kondrashin A; Nesterova M; Cho-Chung YS
    Biochemistry; 1999 Jan; 38(1):172-9. PubMed ID: 9890895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of cAMP/cAMP-dependent protein kinase signaling pathway in regulation of Na+,K+-ATPase upon activation of opioid receptors by morphine.
    Wu ZQ; Li M; Chen J; Chi ZQ; Liu JG
    Mol Pharmacol; 2006 Mar; 69(3):866-76. PubMed ID: 16317112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.